WallStSmart
AGMB

AgomAb Therapeutics NV American Depositary Shares

NASDAQ: AGMB · HEALTHCARE · BIOTECHNOLOGY

$12.18
-16.57% today

Updated 2026-06-05

Market cap
$563.40M
P/E ratio
P/S ratio
EPS (TTM)
$-1.50
Dividend yield
52W range
$9 – $17
Volume
0.1M

AgomAb Therapeutics NV American Depositary Shares (AGMB) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
0 of 1
Last 1 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
Most recent quarter

When is the next earnings report?

Reporting date
December 31, 2025
Consensus EPS estimate
$-41.04
Fiscal period ending
2025-12-31

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+4.7%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+4.7%
2026-04-23
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-04-23$-0.42$10.55$11.05+4.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.42
2025-12-31$-41.04

Frequently asked questions

When does AgomAb Therapeutics NV American Depositary Shares report next earnings?

AgomAb Therapeutics NV American Depositary Shares (AGMB) is scheduled to report earnings on December 31, 2025. The consensus EPS estimate is $-41.04.

Has AgomAb Therapeutics NV American Depositary Shares beaten earnings estimates?

AgomAb Therapeutics NV American Depositary Shares has beaten Wall Street EPS estimates in 0 of its last 1 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.

How does AGMB stock react to earnings?

AGMB has moved an average of +4.7% the day after earnings over its last 1 reports, finishing higher after 1 of them. Next-day moves show how the market digests results in the short term, and repeated dips on strong reports usually mean expectations were already priced in.